This company has been marked as potentially delisted and may not be actively trading. NGM Biopharmaceuticals (NGM) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock NGM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period NGM Biopharmaceuticals Advances in Cancer Cachexia Treatment with NGM120 StudyJune 27, 2025 | tipranks.comBiosion, Inc. Appoints Kedan Lin, Ph.D., as Chief Development Officer and President of Biosion USFebruary 19, 2025 | finance.yahoo.comNGM Bio Announces Appointment of Wendy Yeh, M.D. as Chief Medical OfficerFebruary 4, 2025 | finance.yahoo.comNGM Bio and KdT Ventures Enter into Worldwide License Agreement for NGM313, a Phase 2-ready FGFR1c/ß-Klotho Agonist Drug CandidateDecember 19, 2024 | tmcnet.comNGM Bio and KdT Ventures Enter into Worldwide License Agreement for NGM313, a Phase 2-ready FGFR1c/β-Klotho Agonist Drug CandidateDecember 19, 2024 | finance.yahoo.comVEGFR-2 Antagonists Clinical Trial Pipeline Insights Featuring 25+ Companies | DelveInsightOctober 8, 2024 | finance.yahoo.comRenal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightSeptember 24, 2024 | finance.yahoo.comCEACAM5 Drugs Market Outlook: Rising Cancer Cases and Clinical Trials to Fuel Growth by 2034 | DelveInsightSeptember 17, 2024 | finance.yahoo.comPharmaceutical Intermediates Market Size To Reach USD 14.0 Billion By 2033, at 13.4% CAGR: Insights by Dimension Market ResearchSeptember 9, 2024 | finance.yahoo.comPsychedelic Stock Deep Dive: Atai Life SciencesSeptember 3, 2024 | seekingalpha.comTHE NATIONAL BLACK COLLEGE ALUMNI HALL OF FAME FOUNDATION, INC. ANNOUNCES THE HONOREES FOR INDUCTION INTO THE 2024 HALL OF FAMEAugust 30, 2024 | finance.yahoo.com3 Swedish Growth Companies With Up To 30% Insider OwnershipAugust 14, 2024 | finance.yahoo.comSwedish Growth Companies With High Insider Ownership In July 2024July 26, 2024 | finance.yahoo.comSino Biopharmaceutical Ltd 01177July 26, 2024 | morningstar.comMSwedish Growth Companies With High Insider Ownership And 31% ROEJuly 25, 2024 | finance.yahoo.comXTL Biopharmaceuticals (NASDAQ:XTLB) Stock Quotes, Forecast and News SummaryJuly 22, 2024 | benzinga.comMerck to buy eye drug developer for $1.3BMay 29, 2024 | finance.yahoo.comGlobal Ambulatory Surgical Centers Market is Projected to Boost at a Moderate Growth Rate of ~6% by 2030 | DelveInsightMay 23, 2024 | finance.yahoo.comGlobal Infection Prevention and Control Market is Likely to Increase at a Steady Growth Rate of ~6% by 2030 | DelveInsightMay 22, 2024 | finance.yahoo.comSwedish Exchange Highlights Three Growth Companies With High Insider OwnershipMay 13, 2024 | finance.yahoo.comNGM Biopharmaceuticals, Inc.: NGM Bio Announces Closing of Tender OfferApril 5, 2024 | finanznachrichten.deNGM Bio Announces Closing of Tender OfferApril 5, 2024 | globenewswire.comNGM Biopharmaceuticals (Nasdaq:NGM) HeadlineTrading was temporarily halted for "NGM" at 07:04 PM with a stated reason of "News pending."...April 5, 2024 | marketbeat.comNGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual MeetingMarch 19, 2024 | globenewswire.comNGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGMMarch 13, 2024 | businesswire.comHow a VC and a biotech founder plan to create a new biotech modelMarch 12, 2024 | bizjournals.comOracle, Dollar General upgraded: Wall Street's top analyst callsMarch 12, 2024 | msn.comNGM Biopharmaceuticals (NASDAQ:NGM) Lowered to "Market Perform" at Raymond JamesMarch 12, 2024 | marketbeat.comNGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 11, 2024 | globenewswire.comNGM Biopharmaceuticals (NASDAQ:NGM) Downgraded to Neutral at B. RileyFebruary 29, 2024 | marketbeat.comTD Cowen Downgrades NGM Biopharmaceuticals (NGM)February 29, 2024 | msn.comTD Cowen Downgrades NGM Biopharmaceuticals (NASDAQ:NGM) to Market PerformFebruary 28, 2024 | marketbeat.comNGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGMFebruary 27, 2024 | businesswire.comNGM Biopharmaceuticals (NASDAQ:NGM) Downgraded by CitigroupFebruary 27, 2024 | marketbeat.comThe Column Group moves forward with plan to take NGM Bio privateFebruary 26, 2024 | bizjournals.comNGM Biopharmaceuticals, Inc.: NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LPFebruary 26, 2024 | finanznachrichten.deNGM Bio To Be Acquired By Affiliates Of The Column Group, LPFebruary 26, 2024 | markets.businessinsider.comNGM to go private through deal with investment firmFebruary 26, 2024 | finance.yahoo.comNGM Biopharmaceuticals Shares Drop 20% After $1.55/Shr Buyout OfferFebruary 26, 2024 | marketwatch.comNGM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NGM Biopharmaceuticals, Inc. Is Fair to ShareholdersFebruary 26, 2024 | businesswire.comNGM Biopharmaceuticals Gets Buyout Offer From Column Group AffliatesFebruary 26, 2024 | marketwatch.comNGM Bio to go private in a $135M deal with Atlas NeonFebruary 26, 2024 | msn.comNGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LPFebruary 26, 2024 | globenewswire.comNGM Biopharmaceuticals (Nasdaq:NGM) HeadlineTrading was temporarily halted for "NGM" at 08:02 AM with a stated reason of "News pending."...February 26, 2024 | marketbeat.comNGM Biopharmaceuticals (NGM) Scheduled to Post Earnings on MondayFebruary 25, 2024 | marketbeat.comAscites Market to Observe Stunning Growth During the Study Period (2019–2032) | DelveInsightFebruary 21, 2024 | finance.yahoo.comNGM Bio to Participate in the Cowen 44th Annual Health Care ConferenceFebruary 20, 2024 | finance.yahoo.comNGM Bio to Participate in the Cowen 44th Annual Health Care ConferenceFebruary 20, 2024 | globenewswire.comNGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Sees Significant Increase in Short InterestFebruary 17, 2024 | marketbeat.comNGM Biopharmaceuticals, Inc. (NGM)February 13, 2024 | ca.finance.yahoo.com Get NGM Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NGM and its competitors with MarketBeat's FREE daily newsletter. Email Address NGM Media Mentions By Week NGM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NGM News Sentiment▼0.000.56▲Average Medical News Sentiment NGM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NGM Articles This Week▼00▲NGM Articles Average Week Get NGM Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NGM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PHXM News Today SXTPW News Today DRTSW News Today BCTXW News Today ENGNW News Today FBIOP News Today GOVXW News Today LEXXW News Today NTRBW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NGM) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredNobel Prize Material Finally Goes CommercialA Nobel Prize–winning material just got its biggest breakthrough in 30 years. A little-known company has cr...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NGM Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NGM Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
